The AECG100 multifunction simulator features outputting ECG and PPG analog signals, combined with WhaleTeq exclusive test parameters.

“Chief i Health” integrates exercise, diet, and health-related data collection, conducts intelligent value-added analysis, and promotes personalized health promotion management.

“DKABio Immunity Index” has been developed to increase self-awareness of epidemic prevention and precautions taking because of the prevalence of Covid-19 in 2020.

AFC Easy Care® Reusable Coverall is the first ever reusable personal protective clothing. It is FDA-approved(Class 1) and passes AAMI test requirements.

QQBee Dr.AntiVirus Multi-Purpose Cleaner Antibacterial Spray was resisted with the FDA, Health-Elite High Performance Antibacterial Spray is a spray-on nanocomposite formula that provides an invisible microbiostatic coating on surfaces.

The exclusive “MOTEX Airtight Protective Face Mack” is a significant breakthrough not only in technology but also advancement in fitness that helps to prevent high leak rate as in the traditional face mask.

Our invention demonstrates an integrated platform for disease detection and vaccine production. It simultaneously provides detection products and vaccines for COVID-19.

During the pandemic era, we are willing to distribute any potential medicine having positive effect to Covid-19 treatment to the world, including Hydroxychloroquine, Dexamethasone, Meropenem, and Epinephrine, etc.

Uhlmann track & trace serialization platform-S500 provides serial number marking on vaccine/medicine packaging box and online integration for real-time tracking and traceability, ensuring the safety of vaccines and drugs in a more efficient way.

FP-025 is a highly selective small molecule inhibitors of Matrix Metalloproteinase-12/Macrophage elastase (MMP-12), was shown to have effects in preclinical inflammation and fibrosis models of the lung, making it a promising treatment for inflammatory airway diseases.

UB-612 is a proprietary high-precision designer S1-RBD-protein based vaccine developed by UBI/UBIA Group.

Small-molecule stabilization of protein-protein interactions (PPIs) is a promising strategy in drug discovery.

Nostoc commune are wild vegetables that have high nutritional value. However, they are not easily harvested or cleaned, which reduces their commercial value. Our team not only overcomes the above-mentioned problems through innovative cultivation methods, but also increased algenic acid and phycobiliprotein content. Our novel Nostoc commune can be widely used in the food industry, biomedical field, and health products.

Liquid chromatography mass spectrometry (LCMS) has been the key instrument in advanced analytical laboratories. LCMS often gives the final confirmation of taking illegal drug or food impurities. Nevertheless, all commercial LCMS are bulky and expensive. Therefore, it is impossible to use present commercial LCMS for in-situ real-time analysis. Recently, we developed portable LCMS to make an advanced analytical lab become mobile to easily reach anyplace that needs in-situ, real-time analysis.

ATP BioPharm is an energized start-up biotech company spun out from Taipei Medical University with a focus on drug development for unmet medical needs. Our company is positioned to deliver a best-in-class small molecule from preclinical to clinical stage. ATP BioPharm now possesses a patent-protected HDAC6 inhibitor, MPT0G211.

Upholding the spirit of innovative technology, professional service and quality improvement, We provide perfect BEFORE AND AFTER SERVICES. We are also the agent of many international brands of equipment, from medical materials such as plastic and medical equipment assembly adhesive, to a large number of mass production solutions such as: 128 cavity management of full hot runner mold, automatic feeding and discharging, automatic assembly of needles, automatic detection, smart factory, and Commercial sterilized air purifiers.

Cancer is the leading cause of death with an average of one person dying of cancer every eight minutes worldwide. However, the patient-specific therapy is the pursing answer for all cancer experts. The formation and transfer pattern of cancer is diverse for different cancer types and different patients.

Psoriasis affects approximately 2-3% of the world‘s population and is an autoimmune disease and a chronic inflammatory skin disease as a serious global problem. As first-line treatment for psoriasis, corticosteroids often possess serious long-term side effects. Therefore, the most urgent need for psoriasis therapy is developing drugs for long-term use with high efficacy and little side effects. PTB323X, a new botanical drug for the treatment of psoriasis, is developed by the Botanical Drug Technology Division of the Industrial Research Institute. In addition to effectively improving the symptoms of psoriasiform dermatitis in animals, the efficacy of PTB323X is superior to vitamin D derivative and has no skin-related side effect during the experimental period.

Artificial intelligence and adaptive therapy combine to create Adaptive Intelligence. Technology will inspire you to reimagine how you’re able to treat each patient in your